pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-1185-1 |
Genomic Coordinates | chr14: 101042977 - 101043062 |
Synonyms | MIRN1185-1, hsa-mir-1185-1, MIR1185-1 |
Description | Homo sapiens miR-1185-1 stem-loop |
Comment | This sequence was proposed as a miRNA candidate by Berezikov et al by RAKE analysis . |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-1185-1-3p | ||||||||||||||||||||||||||||||
Sequence | 53| AUAUACAGGGGGAGACUCUUAU |74 | ||||||||||||||||||||||||||||||
Evidence | Not_experimental | ||||||||||||||||||||||||||||||
Experiments | |||||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | MOB4 | ||||||||||||||||||||
Synonyms | 2C4D, CGI-95, MOB1, MOB3, MOBKL3, PHOCN, PREI3 | ||||||||||||||||||||
Description | MOB family member 4, phocein | ||||||||||||||||||||
Transcript | NM_001100819 | ||||||||||||||||||||
Other Transcripts | NM_015387 , NM_199482 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on MOB4 | |||||||||||||||||||||
3'UTR of MOB4 (miRNA target sites are highlighted) |
>MOB4|NM_001100819|3'UTR 1 AGGGAATCATAGGAAAAATGTACTGATCATATAATTAACATTATGTACTGTATATATCATTTTAGACACATCAATCATGT 81 ATCCATATTATAGCTTCTTTGTTTAGTATAGGTTTTTGTATGCTGGGTTTGCCTTTTAAAATGGGAAATACTTTTTAAGT 161 TATTCATAAGCTGTATATTCACCAGTGTGGCACTCATGGTTTTTAAATAAGATTAGTATTATCTGTTTATAATGCCTGTT 241 AATAAAAGAATTTACAGTTTGGTAAAATTGCTGCTAAACAATCATTGGATCACAATCCTCATCAGACAAACCCATCTGTA 321 AAAAAAATGAGGGAGAGCTTGAGGTTTCACACAAGCCATTTACTAAAGAGGTAGAAATGTTTTCTATTGGTTTTACCTTG 401 AGTTTAGATATCCTAAAAAATTCTGTAGTACGTAGTTTTGTCTTACCTGTTAACTTTCCCCAATTGAGATAAAAGTGTTT 481 TAAAATTCTGTTTATAGTTTTTGATATGCATATATAATTATGTGTATATCTAAATACAAATGCAAATGAAGCATTAGTAA 561 TACTTAAATAATTTTACTGTGCTACATAAAGTATAACATACTTGGAAAGGATTTACCGTTCTGCAACAACGGACTGGTAC 641 ATACAGGATGATCACAATGGTAAGGCACATAAATTATTTTCCCACTGGAAACCTGCCCTGTCCACCCCTTCTCATTTCCC 721 TTAACCTTATCTTCAAACTACTTTAGCTGAGAAGCTTTTCACCAGACTGAGTTAGTGGTGGCTTATACCTATTTATATTT 801 GTATTAATTGCTTACAGATTATACCTCATATTAGCAATTACATTACACTACAAGAAAATGTATTTGCATAGGCTCTTGCT 881 TATCTTTGTTTTGCAAAATTGTTCTACTTAGAAAACAGTCCTTAAAATAGTTTGACTCTTCCTGTTAGTAATATATTAAT 961 CTTTCATTTAACCAGCTAGGCAGCATTAAATAGAATTGAAGAAATACCATAGTATTTATTTTACACCCCCTCTCCCACGA 1041 AGTTTATGTTTGGATTACATGCACGTGTGAGATTATTTGCAATAATTCATAGGTTCCAAGGGTGTTGATGAATAGTCATA 1121 CATTTTTTTGGACTTTGTTATAATTCATTGTGGTAAGAATGATTGAAATGCAGATTTAACAATCTTATAATCTATTGAAT 1201 GCCATTTTTGATAAAGCACTGGAGGTCTTATTGCCAAACTGATTGTAATGAGGCAGTAAGGGTGAAAACATTGTACATGT 1281 TGTGAAGAAAGTATTTAAATCCAACTTTTGAACAGATTTAACAAACATGAGGAACTTTTTTATTTAGAAGGATAATTTTG 1361 AAGATGAAAATGTATTCATCTTAATTGTTTTTTCAAATTTAAGGGAATAATTTATACCATCTTTTCAGACAAGAATGTAC 1441 AGCAAAAATAAGGGGAACAGTAGTATACTGAGAGTGTGTGTATGTATAGTGTATGCCTTTCCAAGCTTGCCAGTCTTTTT 1521 GGCTTTGAACACTGCCCATCAGCTACAGTCATTACTGTTCCCCAACCCACAACTATCTTTTAAGAAGTCTTAGTTCACAG 1601 TGAAAGGAATGATGACTTTGAAATTATGGATTTATATTAATGGCACTATAAACCAATGGTAATGGTAATTTTTAAACTTG 1681 CTAAATATTGAGAAACTAAACTACTAAGTTAATAAATTATATATAGCAGTGTAGCTGTTCTCTCTAGATGGTGTCTCACA 1761 ATGGATTTCTGTTGCTTGACTATTTTCTTAGTGAATATTTATACTAAGGTAGTGACTGAGATTTGGTGATCTGGCTGAGT 1841 ATTTTGAAACACATTTTGAATAATATGGCTTAGTGTTAACGGGGACTTAAATATGATTTTTTTTTCTTACTCATTTCACC 1921 TTCCCTGTACTGTATGTTTGGAATTGATCATAAAACATCTCCAAAAGAAAATAATCAGTTTGTAGTCTTGCTTTTGTATT 2001 CATGTTGATAATCTTACTAATTGTGAAGTTGATTCACTACTATACTAGGTAAGACCTAAGTGAAACAGTTCCTGTTTTTC 2081 CTTAATACTGTTTTCAGAATTTTGAAAATGTACTTATATATACATAAATACTACTAAAAAATTAATGAGCCTGGCAAACC 2161 ATTGATTTATAAAAGTAAGTGTTCTAAGAGGGGAACAAGACAGTTCTGTGTGATAAGGAAGTTAGGCTCCACTTTTTGTT 2241 TGAATTACCCTATGTATATCCGAAGGTAAACTTAGGCTTTTCTTTCCAAAAGATCGTATAGTCAATTCATTCTTTTTCTC 2321 CTATCACATCTGGGAAAGTAGCTAACTTTTAACTATTTATGTTCCCATAAGTAACCCTTCTTTTGTGTGTATACATTTCC 2401 TTTTCTCTGACTTGAGATGTCAAATTTGGATTTCTAGAACAGTTTCTCAGTTAAATTCTTGATGACTTAACAACTTTTAC 2481 TATCAGAATACAATTAGAAATCCTTGGTCAGGCACAGGGGCTCACGCCTGTAATCCCAGCACTTTGGGAAGCCAAGGCAG 2561 ACAGATCACCTGAGGTCAGGAGTTCGAGACCAGCCTGACCAACATGGAGAAACCCTGTCTCTACTAAAAATACAAAAATT 2641 AGCCGGGCGTGGTGCTACTCGTGAGGCTGAGGCAGGAGAATCGCTTGAACCCGGGAGGTGGAGGTTGCGGTGAGCTGAGA 2721 TCGTGCCATTGCACTCCAGCCTGGGTAACGAGCAAAACTCCGTCTCAAAAACTCCGTCTCAAAAAAAAAAAATCCTTGAT 2801 TACATTGTTAGTAAGGACTGTGTTACGATTATAAACACATTTATTGGTTGATGTCAAATTCACTGTAATAGTAGAACTAA 2881 GTTTTTTATGTGAGTACTTTGCCCTACTGTCTATATGATGACATCTTTTTTGAGCAGCTAAATTTTAAATTGTATATACT 2961 TTATTTTGTGAATCCTTGTTGAATGTGCTAAAGGTTTCTTTGTGTAGTTCTTCCATGCTATGCGAATATTTTAGTAAAAG 3041 TAGTTGATTTTTAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
CLIP-seq Support 1 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000233892.4 | 3UTR | CUGAUCAUAUAAUUAACAUUAUGUACUGUAUAUAUCAUUUUAGACACAUCAAUCAUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
114 hsa-miR-1185-1-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT066415 | TBK1 | TANK binding kinase 1 | 2 | 4 | ||||||||
MIRT073567 | NR2F2 | nuclear receptor subfamily 2 group F member 2 | 2 | 2 | ||||||||
MIRT074516 | USP1 | ubiquitin specific peptidase 1 | 2 | 4 | ||||||||
MIRT080576 | PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 2 | 6 | ||||||||
MIRT086539 | HSPE1-MOB4 | HSPE1-MOB4 readthrough | 2 | 2 | ||||||||
MIRT086547 | MOB4 | MOB family member 4, phocein | 2 | 2 | ||||||||
MIRT088684 | EML4 | echinoderm microtubule associated protein like 4 | 2 | 4 | ||||||||
MIRT090811 | MBNL1 | muscleblind like splicing regulator 1 | 2 | 4 | ||||||||
MIRT095500 | PURA | purine rich element binding protein A | 2 | 2 | ||||||||
MIRT109530 | KLHL15 | kelch like family member 15 | 2 | 6 | ||||||||
MIRT109807 | ZFX | zinc finger protein, X-linked | 2 | 2 | ||||||||
MIRT117888 | ZBTB7A | zinc finger and BTB domain containing 7A | 2 | 2 | ||||||||
MIRT120273 | GSK3B | glycogen synthase kinase 3 beta | 2 | 4 | ||||||||
MIRT149892 | LDLR | low density lipoprotein receptor | 2 | 2 | ||||||||
MIRT178475 | LCOR | ligand dependent nuclear receptor corepressor | 2 | 4 | ||||||||
MIRT193445 | RORA | RAR related orphan receptor A | 2 | 2 | ||||||||
MIRT198527 | DSG2 | desmoglein 2 | 2 | 2 | ||||||||
MIRT226427 | TP53INP1 | tumor protein p53 inducible nuclear protein 1 | 2 | 2 | ||||||||
MIRT227669 | SET | SET nuclear proto-oncogene | 2 | 2 | ||||||||
MIRT320405 | HOXA9 | homeobox A9 | 2 | 2 | ||||||||
MIRT407774 | MRPL35 | mitochondrial ribosomal protein L35 | 2 | 2 | ||||||||
MIRT439228 | ZMIZ1 | zinc finger MIZ-type containing 1 | 1 | 1 | ||||||||
MIRT439312 | VAT1L | vesicle amine transport 1 like | 1 | 1 | ||||||||
MIRT439421 | TMOD1 | tropomodulin 1 | 1 | 1 | ||||||||
MIRT439446 | TMEM104 | transmembrane protein 104 | 1 | 1 | ||||||||
MIRT439524 | STIM2 | stromal interaction molecule 2 | 1 | 1 | ||||||||
MIRT439612 | SLC29A1 | solute carrier family 29 member 1 (Augustine blood group) | 1 | 1 | ||||||||
MIRT439997 | PFKFB2 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 | 1 | 1 | ||||||||
MIRT440017 | PCSK1 | proprotein convertase subtilisin/kexin type 1 | 1 | 1 | ||||||||
MIRT440131 | NCOA4 | nuclear receptor coactivator 4 | 1 | 1 | ||||||||
MIRT440311 | LRRC1 | leucine rich repeat containing 1 | 1 | 1 | ||||||||
MIRT440475 | IAPP | islet amyloid polypeptide | 1 | 1 | ||||||||
MIRT440511 | HERC2 | HECT and RLD domain containing E3 ubiquitin protein ligase 2 | 1 | 1 | ||||||||
MIRT440617 | FOXA2 | forkhead box A2 | 1 | 1 | ||||||||
MIRT440666 | FBXL16 | F-box and leucine rich repeat protein 16 | 1 | 1 | ||||||||
MIRT440705 | ERO1LB | endoplasmic reticulum oxidoreductase 1 beta | 1 | 1 | ||||||||
MIRT441007 | CAPZA2 | capping actin protein of muscle Z-line alpha subunit 2 | 1 | 1 | ||||||||
MIRT441018 | CAND1 | cullin associated and neddylation dissociated 1 | 1 | 1 | ||||||||
MIRT441062 | C1orf43 | chromosome 1 open reading frame 43 | 1 | 1 | ||||||||
MIRT441209 | ARCN1 | archain 1 | 1 | 1 | ||||||||
MIRT449461 | HAT1 | histone acetyltransferase 1 | 2 | 2 | ||||||||
MIRT467104 | SRI | sorcin | 2 | 2 | ||||||||
MIRT468060 | SHOC2 | SHOC2, leucine rich repeat scaffold protein | 2 | 10 | ||||||||
MIRT468476 | SESN3 | sestrin 3 | 2 | 4 | ||||||||
MIRT473533 | MAX | MYC associated factor X | 2 | 2 | ||||||||
MIRT473852 | MAP2K4 | mitogen-activated protein kinase kinase 4 | 2 | 2 | ||||||||
MIRT474711 | KIF13A | kinesin family member 13A | 2 | 6 | ||||||||
MIRT481665 | ARAP2 | ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 | 2 | 2 | ||||||||
MIRT485120 | SF3B3 | splicing factor 3b subunit 3 | 2 | 2 | ||||||||
MIRT493055 | MTFR1 | mitochondrial fission regulator 1 | 2 | 2 | ||||||||
MIRT504258 | C1orf147 | chromosome 1 open reading frame 147 | 2 | 4 | ||||||||
MIRT504361 | ARID1B | AT-rich interaction domain 1B | 2 | 4 | ||||||||
MIRT505748 | SENP1 | SUMO1/sentrin specific peptidase 1 | 2 | 8 | ||||||||
MIRT506298 | PCMTD1 | protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1 | 2 | 6 | ||||||||
MIRT508442 | ZNF608 | zinc finger protein 608 | 2 | 4 | ||||||||
MIRT512782 | COL4A3BP | collagen type IV alpha 3 binding protein | 2 | 2 | ||||||||
MIRT520447 | TSPAN2 | tetraspanin 2 | 2 | 4 | ||||||||
MIRT522133 | NRBF2 | nuclear receptor binding factor 2 | 2 | 6 | ||||||||
MIRT522395 | MYADM | myeloid associated differentiation marker | 2 | 4 | ||||||||
MIRT523397 | GRIK3 | glutamate ionotropic receptor kainate type subunit 3 | 2 | 4 | ||||||||
MIRT523938 | E2F8 | E2F transcription factor 8 | 2 | 4 | ||||||||
MIRT524349 | CREB1 | cAMP responsive element binding protein 1 | 2 | 2 | ||||||||
MIRT524711 | BRMS1L | breast cancer metastasis-suppressor 1 like | 2 | 4 | ||||||||
MIRT525134 | ZNF256 | zinc finger protein 256 | 2 | 2 | ||||||||
MIRT525710 | DCAF12L2 | DDB1 and CUL4 associated factor 12 like 2 | 2 | 2 | ||||||||
MIRT531264 | PPIL3 | peptidylprolyl isomerase like 3 | 2 | 2 | ||||||||
MIRT538844 | BTG1 | BTG anti-proliferation factor 1 | 2 | 2 | ||||||||
MIRT541366 | CDKN1B | cyclin dependent kinase inhibitor 1B | 2 | 2 | ||||||||
MIRT542093 | KCNK10 | potassium two pore domain channel subfamily K member 10 | 2 | 6 | ||||||||
MIRT543770 | RBM12B | RNA binding motif protein 12B | 2 | 4 | ||||||||
MIRT543940 | NCOA7 | nuclear receptor coactivator 7 | 2 | 2 | ||||||||
MIRT545150 | GABRG1 | gamma-aminobutyric acid type A receptor gamma1 subunit | 2 | 2 | ||||||||
MIRT545842 | ZNF264 | zinc finger protein 264 | 2 | 4 | ||||||||
MIRT548057 | GOLGA7 | golgin A7 | 2 | 2 | ||||||||
MIRT549242 | ATXN1L | ataxin 1 like | 2 | 4 | ||||||||
MIRT551829 | AASDHPPT | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | 2 | 2 | ||||||||
MIRT552484 | ZNF136 | zinc finger protein 136 | 2 | 2 | ||||||||
MIRT553663 | TGFBR2 | transforming growth factor beta receptor 2 | 2 | 2 | ||||||||
MIRT554988 | RAB39B | RAB39B, member RAS oncogene family | 2 | 2 | ||||||||
MIRT555760 | PCTP | phosphatidylcholine transfer protein | 2 | 2 | ||||||||
MIRT556923 | IRF2BP2 | interferon regulatory factor 2 binding protein 2 | 2 | 4 | ||||||||
MIRT564991 | WNK1 | WNK lysine deficient protein kinase 1 | 2 | 2 | ||||||||
MIRT566458 | PGGT1B | protein geranylgeranyltransferase type I subunit beta | 2 | 2 | ||||||||
MIRT566538 | PANK3 | pantothenate kinase 3 | 2 | 2 | ||||||||
MIRT567732 | DLX2 | distal-less homeobox 2 | 2 | 2 | ||||||||
MIRT570081 | KANSL1L | KAT8 regulatory NSL complex subunit 1 like | 2 | 2 | ||||||||
MIRT571735 | RNF11 | ring finger protein 11 | 2 | 2 | ||||||||
MIRT573529 | MDM2 | MDM2 proto-oncogene | 2 | 2 | ||||||||
MIRT574459 | RPS16 | ribosomal protein S16 | 2 | 2 | ||||||||
MIRT574992 | Phka1 | phosphorylase kinase alpha 1 | 2 | 3 | ||||||||
MIRT576349 | Pxdn | peroxidasin | 2 | 2 | ||||||||
MIRT610196 | CD99 | CD99 molecule (Xg blood group) | 2 | 4 | ||||||||
MIRT612920 | GPRIN3 | GPRIN family member 3 | 2 | 2 | ||||||||
MIRT615021 | DUSP6 | dual specificity phosphatase 6 | 2 | 2 | ||||||||
MIRT623573 | IRS1 | insulin receptor substrate 1 | 2 | 2 | ||||||||
MIRT624437 | CASD1 | CAS1 domain containing 1 | 2 | 2 | ||||||||
MIRT628714 | ZNF585A | zinc finger protein 585A | 2 | 2 | ||||||||
MIRT639565 | PCK1 | phosphoenolpyruvate carboxykinase 1 | 2 | 4 | ||||||||
MIRT641485 | POLA2 | DNA polymerase alpha 2, accessory subunit | 2 | 2 | ||||||||
MIRT641657 | PAPOLG | poly(A) polymerase gamma | 2 | 2 | ||||||||
MIRT642210 | RUVBL2 | RuvB like AAA ATPase 2 | 2 | 2 | ||||||||
MIRT653010 | STX7 | syntaxin 7 | 2 | 2 | ||||||||
MIRT656130 | MSH6 | mutS homolog 6 | 2 | 2 | ||||||||
MIRT656893 | KIAA2018 | upstream transcription factor family member 3 | 2 | 2 | ||||||||
MIRT660130 | BRPF3 | bromodomain and PHD finger containing 3 | 2 | 2 | ||||||||
MIRT660855 | AFAP1 | actin filament associated protein 1 | 2 | 2 | ||||||||
MIRT676843 | PHKA1 | phosphorylase kinase regulatory subunit alpha 1 | 2 | 3 | ||||||||
MIRT681473 | DIP2A | disco interacting protein 2 homolog A | 2 | 2 | ||||||||
MIRT682253 | RS1 | retinoschisin 1 | 2 | 2 | ||||||||
MIRT694296 | COPB2 | coatomer protein complex subunit beta 2 | 2 | 2 | ||||||||
MIRT694401 | ALDH1A3 | aldehyde dehydrogenase 1 family member A3 | 2 | 2 | ||||||||
MIRT705277 | BACH1 | BTB domain and CNC homolog 1 | 2 | 2 | ||||||||
MIRT720833 | C1orf52 | chromosome 1 open reading frame 52 | 2 | 2 | ||||||||
MIRT735713 | SIRT1 | sirtuin 1 | 2 | 0 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|